Results per Page:
Dr. Soheil Meshinchi, a leading expert in acute myeloid leukemia, named Dylan Burke Endowed Chair in Immunotherapy
Meshinchi’s research training the body to fight cancer is expanding from blood cancers to solid tumors
For many blood cancer patients, CAR T-cell therapy is game-changing
In this episode of From Bench to Bedside and Beyond, Dr. Mazyar Shadman explains why CAR T-cell therapy should be considered for patients who relapse
Delivering the best possible cancer care
Chief medical officer Tom Purcell emphasizes the importance of improving the patient experience
Fred Hutch study finds new life for ‘ineffective’ drugs
Innovative method using more authentic tumor samples reveals untapped potential for drugs written off by more conventional tests
Patients’ own autoantibodies may hold key to boosting cancer immunotherapy response
A study published in Nature finds that some cancer patients can make their “own companion drug,” suggesting a potential template for future treatments
Conditionally activated immunotherapies alleviate cancer treatment toxicity
From the Fong Lab, Translational Sciences and Therapeutics
Improving delivery of monoclonal antibody therapies in resource-limited settings
From researchers in the Translational Sciences and Therapeutics and Vaccines and Infectious Disease Divisions